Stifel Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $28
Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $32
Buy Rating for DENTSPLY SIRONA on Next-Gen Dental Innovations and Strategic Growth Potential
Baird Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $31
Leerink Partners Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Announces Target Price $34
Piper Sandler Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $32
Evercore Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Raises Target Price to $29
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY) and Travere Therapeutics (TVTX)
Piper Sandler Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)
Dentsply Sirona Analyst Ratings
Barrington Research Maintains Outperform on Dentsply Sirona, Maintains $36 Price Target
Barrington Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $36
DENTSPLY SIRONA: Poised for Growth With Strategic Initiatives and Strong FY/26 Targets—A Buy Recommendation
Leerink Partners Maintains Dentsply Sirona(XRAY.US) With Buy Rating
DENTSPLY SIRONA (XRAY) Receives a Buy From Leerink Partners
DENTSPLY SIRONA: A Buy Rating Amid CFO Transition and Robust Growth Targets
Dentsply Sirona Analyst Ratings
Needham Reiterates Buy on Dentsply Sirona, Maintains $34 Price Target
Needham Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $34
Buy Rating Affirmed Despite CFO Departure: Confidence in DENTSPLY SIRONA's Strategic Initiatives and Growth Prospects